-
Je něco špatně v tomto záznamu ?
The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel
G. Kassianos, JM. Cohen, R. Civljak, N. Davidovitch, OF. Pecurariu, F. Froes, A. Galev, I. Ivaskeviciene, K. Kõivumägi, Z. Kristufkova, E. Kuchar, J. Kyncl, HC. Maltezou, M. Marković, A. Nitsch-Osuch, R. Ortiz de Lejarazu, A. Rossi, J. Schelling,...
Jazyk angličtina Země Anglie, Velká Británie
Typ dokumentu časopisecké články, přehledy
- MeSH
- chřipka lidská * prevence a kontrola epidemiologie MeSH
- COVID-19 * prevence a kontrola epidemiologie MeSH
- hospitalizace * statistika a číselné údaje MeSH
- lidé MeSH
- pokrytí očkováním * statistika a číselné údaje MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- vakcíny proti chřipce * aplikace a dávkování MeSH
- Check Tag
- lidé MeSH
- senioři nad 80 let MeSH
- senioři MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Geografické názvy
- Evropa MeSH
- Izrael MeSH
INTRODUCTION: The Raise Awareness of Influenza Strategies in Europe (RAISE) group gathered information about the healthcare burden of influenza (hospitalizations, intensive care unit [ICU] admissions, and excess deaths), surveillance systems, and the vaccine coverage rate (VCR) in older adults in 18 European countries and Israel. AREAS COVERED: Published medical literature and official medical documentation on the influenza disease burden in the participating countries were reviewed from 2010/11 until the 2022/23 influenza seasons. Information on the framework for monitoring the disease burden and the provision for ensuring older adults had access to vaccination in their respective countries was provided. Data on influenza VCR in older adults were collected for the 2019/20 to 2022/23 influenza seasons. Data are reported descriptively. EXPERT OPINION: Influenza presents a significant healthcare burden in older adults. Reporting outcomes across participating countries is heterogeneous, highlighting the need for standardized approaches. Although older adults receive free influenza vaccination, vaccine uptake is highly variable among countries. Moreover, hospitalization rates remain high even in countries reporting a high VCR. Increased awareness and education on the burden of disease and the broader use of improved influenza vaccines for older adults may help reduce the disease burden on this population.
British Global and Travel Health Association Bath UK
Children's Clinic Hospital Brasov Romania
Department for Infectious Diseases University of Zagreb School of Medicine Zagreb Croatia
Department of Epidemiology and Biostatistics Medicine Charles University Prague Czech Republic
Department of Paediatrics Riga Stradins University Latvia Europe
Department of Social Medicine and Public Health Medical University of Warsaw Warsaw Poland
Faculty of Medicine Transilvania University Brasov Brasov Romania
Family Vaccination Centre Children's Clinical University Hospital Riga Latvia
General Medicine University of Perugia Perugia Italy
General Practitioner Amersfoort The Netherlands
Immunology Institute of Microbiology and Immunology Medicine University of Belgrade Belgrade Serbia
Institute of Clinical Medicine University of Tartu Tartu Estonia
Labo UR4129 P2S Université Lyon 1 Lyon France
Medizinische Klinik 4 Klinikum der Ludwig Maximilians Universität München Deutschland Europe
Research Studies and Documentation National Public Health Organization Athens Greece
School of Public Health Ben Guiron University of the Negev Beer Sheva Israel
Thorax Department Centro Hospitalar Universitário Lisboa Norte Lisbon Portugal
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24014551
- 003
- CZ-PrNML
- 005
- 20240905134121.0
- 007
- ta
- 008
- 240725s2024 enk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1080/17476348.2024.2340470 $2 doi
- 035 __
- $a (PubMed)38652642
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a enk
- 100 1_
- $a Kassianos, George $u British Global & Travel Health Association, Bath, UK
- 245 14
- $a The influenza landscape and vaccination coverage in older adults during the SARS-Cov-2 pandemic: data from Several European Countries and Israel / $c G. Kassianos, JM. Cohen, R. Civljak, N. Davidovitch, OF. Pecurariu, F. Froes, A. Galev, I. Ivaskeviciene, K. Kõivumägi, Z. Kristufkova, E. Kuchar, J. Kyncl, HC. Maltezou, M. Marković, A. Nitsch-Osuch, R. Ortiz de Lejarazu, A. Rossi, J. Schelling, GA. van Essen, D. Zavadska
- 520 9_
- $a INTRODUCTION: The Raise Awareness of Influenza Strategies in Europe (RAISE) group gathered information about the healthcare burden of influenza (hospitalizations, intensive care unit [ICU] admissions, and excess deaths), surveillance systems, and the vaccine coverage rate (VCR) in older adults in 18 European countries and Israel. AREAS COVERED: Published medical literature and official medical documentation on the influenza disease burden in the participating countries were reviewed from 2010/11 until the 2022/23 influenza seasons. Information on the framework for monitoring the disease burden and the provision for ensuring older adults had access to vaccination in their respective countries was provided. Data on influenza VCR in older adults were collected for the 2019/20 to 2022/23 influenza seasons. Data are reported descriptively. EXPERT OPINION: Influenza presents a significant healthcare burden in older adults. Reporting outcomes across participating countries is heterogeneous, highlighting the need for standardized approaches. Although older adults receive free influenza vaccination, vaccine uptake is highly variable among countries. Moreover, hospitalization rates remain high even in countries reporting a high VCR. Increased awareness and education on the burden of disease and the broader use of improved influenza vaccines for older adults may help reduce the disease burden on this population.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a chřipka lidská $x prevence a kontrola $x epidemiologie $7 D007251
- 650 _2
- $a senioři $7 D000368
- 650 12
- $a pokrytí očkováním $x statistika a číselné údaje $7 D000073887
- 650 12
- $a vakcíny proti chřipce $x aplikace a dávkování $7 D007252
- 650 12
- $a COVID-19 $x prevence a kontrola $x epidemiologie $7 D000086382
- 650 12
- $a hospitalizace $x statistika a číselné údaje $7 D006760
- 650 _2
- $a senioři nad 80 let $7 D000369
- 651 _2
- $a Izrael $x epidemiologie $7 D007557
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Cohen, Jean-Marie $u Open Rome, Paris, France $u Labo UR4129 / P2S, Université Lyon 1, Lyon, France
- 700 1_
- $a Civljak, Rok $u Department for Infectious Diseases, University of Zagreb School of Medicine, Zagreb, Croatia $u Department for Acute Respiratory Infections (Head), Dr. Fran Mihaljevic University Hospital for Infectious Diseases, Zagreb, Croatia
- 700 1_
- $a Davidovitch, Nadav $u School of Public Health, Ben Guiron University of the Negev, Beer-Sheva, Israel
- 700 1_
- $a Pecurariu, Oana Falup $u Faculty of Medicine, Transilvania University Brasov, Brasov, Romania $u Children's Clinic Hospital, Brasov, Romania
- 700 1_
- $a Froes, Filipe $u Thorax Department, Centro Hospitalar Universitário Lisboa Norte, Lisbon, Portugal
- 700 1_
- $a Galev, Andrei $u Scientific Applied Center for Military Epidemiology and Hygiene, Military Medical Academy, Sofiâ, Bulgaria
- 700 1_
- $a Ivaskeviciene, Inga $u Paediatirc Infectious Disease, Clinic of Children'sChildren's Diseases, Institute of Clinical Medicine, Medicine, Vilnius University, Vilnius, Lithuania
- 700 1_
- $a Kõivumägi, Kadri $u Institute of Clinical Medicine, University of Tartu, Tartu, Estonia
- 700 1_
- $a Kristufkova, Zuzana $u Medical Epidemiologist and Head of Department, Department of Epidemiology, Faculty of Public Health, Slovak Medical University Bratislava, Bratislava, Slovakia
- 700 1_
- $a Kuchar, Ernest $u Head of Department,Department of Pediatrics with Clinical Assessment Unit, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Kyncl, Jan $u Medical Epidemiologist and Head of Department, Department of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic $u Department of Epidemiology and Biostatistics, Medicine, Charles University, Prague, Czech Republic
- 700 1_
- $a Maltezou, Helena C $u Research, Studies, and Documentation, National Public Health Organization, Athens, Greece $1 https://orcid.org/0000000302643547
- 700 1_
- $a Marković, Miloš $u Immunology, Institute of Microbiology and Immunology, Medicine, University of Belgrade, Belgrade, Serbia
- 700 1_
- $a Nitsch-Osuch, Aneta $u Department of Social Medicine and Public Health, Medical University of Warsaw, Warsaw, Poland
- 700 1_
- $a Ortiz de Lejarazu, Raul $u National Influenza Centre, Hospital Clínico Universitario and University of Valladolid, Valladoild, Spain
- 700 1_
- $a Rossi, Alessandro $u General Medicine, University of Perugia, Perugia, Italy
- 700 1_
- $a Schelling, Jörg $u Medizinische Klinik IV, Klinikum der Ludwig-Maximilians-Universität München, Deutschland, Europe
- 700 1_
- $a van Essen, Gerrit A $u General Practitioner, Amersfoort, The Netherlands
- 700 1_
- $a Zavadska, Dace $u Department of Paediatrics, Riga Stradins University, Latvia, Europe $u Family Vaccination Centre, Children's Clinical University Hospital, Riga, Latvia
- 773 0_
- $w MED00174437 $t Expert review of respiratory medicine $x 1747-6356 $g Roč. 18, č. 3-4 (2024), s. 69-84
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/38652642 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240725 $b ABA008
- 991 __
- $a 20240905134115 $b ABA008
- 999 __
- $a ok $b bmc $g 2143989 $s 1226417
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 18 $c 3-4 $d 69-84 $e 20240508 $i 1747-6356 $m Expert review of respiratory medicine $n Expert Rev Respir Med $x MED00174437
- LZP __
- $a Pubmed-20240725
